TY - JOUR
T1 - Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study
AU - von Scheibler, E.N.M.M.
AU - Bouman, E.S.V.
AU - Nuijts, M.A.
AU - Bauer, N.J.C.
AU - Berendschot, T.T.J.M.
AU - Vermeltfoort, P.
AU - Bok, L.A.
AU - van Eeghen, A.M.
AU - Houben, M.L.
AU - van Amelsvoort, T.A.M.J.
AU - Boot, E.
AU - van Egmond-Ebbeling, M.B.
PY - 2022/2
Y1 - 2022/2
N2 - The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem disorder with an estimated prevalence of 1:3000 live births. Manifestations show a marked variability in expression and include speech- and language delay, intellectual disability, and neuropsychiatric disorders. We aim to provide an overview of ocular findings in 22q11.2DS in order to optimize recommendations for ophthalmic screening. We combined results from a systematic literature review with results from a multicenter cross-sectional study of patients with 22q11.2DS who were assessed by an ophthalmologist. Our systematic literature search yielded four articles, describing 270 patients. We included 132 patients in our cross-sectional study (median age 8.9 [range 0-56] years). Most reported ocular findings were retinal vascular tortuosity (32%-78%), posterior embryotoxon (22%-50%), eye lid hooding (20%-67%), strabismus (12%-36%), amblyopia (2%-11%), ptosis (4%-6%), and refractive errors, of which hyperopia (6%-48%) and astigmatism (3%-23%) were most common. Visual acuity was (near) normal in most patients (91%-94%). Refractive errors, strabismus, and amblyopia are treatable conditions that are frequently present in patients with 22q11.2DS and should be corrected at an early stage. Therefore, in 22q11.2DS, we recommend ophthalmic and orthoptic screening at the age of 3 years or at diagnosis, and a low-threshold referral in adults.
AB - The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem disorder with an estimated prevalence of 1:3000 live births. Manifestations show a marked variability in expression and include speech- and language delay, intellectual disability, and neuropsychiatric disorders. We aim to provide an overview of ocular findings in 22q11.2DS in order to optimize recommendations for ophthalmic screening. We combined results from a systematic literature review with results from a multicenter cross-sectional study of patients with 22q11.2DS who were assessed by an ophthalmologist. Our systematic literature search yielded four articles, describing 270 patients. We included 132 patients in our cross-sectional study (median age 8.9 [range 0-56] years). Most reported ocular findings were retinal vascular tortuosity (32%-78%), posterior embryotoxon (22%-50%), eye lid hooding (20%-67%), strabismus (12%-36%), amblyopia (2%-11%), ptosis (4%-6%), and refractive errors, of which hyperopia (6%-48%) and astigmatism (3%-23%) were most common. Visual acuity was (near) normal in most patients (91%-94%). Refractive errors, strabismus, and amblyopia are treatable conditions that are frequently present in patients with 22q11.2DS and should be corrected at an early stage. Therefore, in 22q11.2DS, we recommend ophthalmic and orthoptic screening at the age of 3 years or at diagnosis, and a low-threshold referral in adults.
KW - 22q11
KW - 2 deletion syndrome
KW - CNV
KW - cross-sectional study
KW - ophthalmology
KW - systematic review
KW - RETINAL VASCULAR TORTUOSITY
KW - REFRACTIVE ERRORS
KW - CLINICAL-FEATURES
KW - VISUAL IMPAIRMENT
KW - PREVALENCE
KW - CHILDREN
KW - ADULTS
KW - ASTIGMATISM
KW - DISORDERS
KW - ANOMALIES
U2 - 10.1002/ajmg.a.62556
DO - 10.1002/ajmg.a.62556
M3 - (Systematic) Review article
C2 - 34773366
SN - 1552-4825
VL - 188
SP - 569
EP - 578
JO - American Journal of Medical Genetics Part A
JF - American Journal of Medical Genetics Part A
IS - 2
ER -